Several CNAs, in particular loss of CDKN2A, exhibited prognostic significance in PTCL-NOS as a single entity and in the PTCL-GATA3 subgroup. This evidence concerns the gene CDKN2A and mature T-cell and NK-cell non-Hodgkin lymphoma.